Gonca BEKTAŞ, Melis ULAK ÖZKAN, Edibe PEMBEGÜL YILDIZ, Tuğçe AKSU UZUNHAN, Serra SENCER, Nur AYDINLI, Mine ÇALIŞKAN, Meral ÖZMEN

Clinically isolated syndrome and multiple sclerosis in children: a single center study

Background and objectives. This study was conducted to determine the differences in clinical and radiological features at the first demyelinating event in children with clinically isolated syndrome (CIS) and multiple sclerosis (MS). Methods. This was a single center retrospective cohort study of the children with CIS followed-up at Istanbul University Faculty of Medicine, Department of Pediatric Neurology, between 2010 and 2018. Children with CIS who were assessed at 3, 6, 12 and 24 months following their first identified demyelinating event were included. Demographic data, mode of presentation and the presence of the oligoclonal band in the cerebrospinal fluid (CSF) were abstracted from the medical records. Magnetic resonance imaging of the brain and spinal cord was analyzed for the location, number, size and gadolinium enhancement of the lesions. Results. A total of 51 patients’ data was assessed, 38 patients at a mean age of 12.3 years were enrolled in the study. Twenty-seven children (71%) evolved into clinically definite MS after a mean follow-up of 11 months. Older age at first demyelinating event and the presence of the oligoclonal band in CSF were tended to be more common in patients with MS than patients with CIS (p

PDF

___

1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6: 887-902.

2. Chitnis T, Tenembaum S, Banwell B, et al; International Pediatric Multiple Sclerosis Study Group Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler J 2012; 18: 116-127.

3. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012; 11: 157-169.

4. Tintore M, Rovira A, Rio J, et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015; 138(Pt 7): 1863-1874.

5. Kappos L, Freedman MS, Polman CH, et al; BENEFIT Study Group Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: A 3-year follow-up analysis of the BENEFIT study. Lancet 2007; 370: 389-397.

6. Sadaka Y, Verhey LH, Shroff MM, et al; Canadian Pediatric Demyelinating Disease Network 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol 2012; 72: 211-223.

7. Krupp LB, Tardieu M, Amato MP, et al; International Pediatric Multiple Sclerosis Study Group International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler J 2013; 19: 1261-1267.

8. Peche SS, Alshekhlee A, Kelly J, Lenox J, Mar S. A long-term follow-up study using IPMSSG criteria in children with CNS demyelination. Pediatr Neurol 2013; 49: 329-334.

9. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68(16 Suppl 2): S7-S12.

10. Dale RC, Pillai SC. Early relapse risk after a first CNS inflammatory demyelination episode: Examining International consensus definitions. Dev Med Child Neurol 2007; 49: 887-893.

11. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008; 71: 967-973.

12. Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: Comparison of presenting features. Dev Med Child Neurol 2009; 51: 480-486.

13. Tantsis EM, Prelog K, Brilot F, Dale RC. Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: Clinical, radiological features and application of the McDonald 2010 MRI criteria. Mult Scler J 2013; 19: 1749-1759.

14. Van der Vuurst de Vries RM, van Pelt ED, Mescheriakova JY, et al. Disease course after clinically isolated syndrome in children versus adults: A prospective cohort study. Eur J Neurol 2017; 24: 315-321.

15. Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: Acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2009; 22: 233-240.

16. Waldman AT, Stull LB, Galetta SL, Balcer LJ, Liu GT. Pediatric optic neuritis and risk of multiple sclerosis: Meta-analysis of observational studies. J AAPOS 2011; 15: 441-446.

17. Mikaeloff Y, Suissa S, Vallee L, et al; KIDMUS Study Group. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004; 144: 246-252.

18. Chabas D, Ness J, Belman A, et al; For the US Network of Pediatric MS Centers of Excellence Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 2010; 74: 399-405.

19. Tur C, Montalban X. CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: No. Mult Scler J 2013; 19: 717-718.

20. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A Prospective National Cohort Study. Lancet Neurol 2011; 10: 436-445.

21. Ghezzi A, Pozzilli C, Liguori M, et al. Prospective study of multiple sclerosis with early onset. Mult Scler J 2002; 8: 115-118.

22. Ghezzi A, Deplano V, Faroni J, et al. Multiple sclerosis in childhood: Clinical features of 149 cases. Mult Scler J 1997; 3: 43-46.

23. Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006; 67: 258-262.

24. Alper G, Wang L. Demyelinating optic neuritis in children. J Child Neurol 2009; 24: 45-48.

25. Heussinger N, Kontopantelis E, Rompel O, Paulides M, Trollmann R. Predicting multiple sclerosis following isolated optic neuritis in children. Eur J Neurol 2013; 20: 1292-1296.

26. Lucchinetti CF, Kiers L, O’Duffy A, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997; 49: 1413-1418.

27. Chabas D, Ness J, Belman A; US Network of Pediatric MS Centers of Excellence Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 2010; 74: 399-405.

28. Kuhle J, Disanto G, Dobson R, et al. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicenter study. Mult Scler J 2015; 21: 1013- 1024.

29. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: A 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131(Pt 3): 808-817.

30. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158-164.

31. Pröbstel AK, Rudolf G, Dornmair K, et al. AntiMOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation 2015; 12: 46.